JB Pharma: Betting big on India
Our biggest bet is India and the CDMO space, says Nikhil Chopra, CEO, JB Pharma, taking stock of the company's ongoing transition…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
domestic formulations business
Aurobindo Pharma acquires domestic formulations business of Veritaz Healthcare
The transaction, which comes into effect from 1st April, 2022, and is expected to close by May 2022, is agreed at a consideration…